397 related articles for article (PubMed ID: 30121291)
1. Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab.
Brunner PM; Pavel AB; Khattri S; Leonard A; Malik K; Rose S; Jim On S; Vekaria AS; Traidl-Hoffmann C; Singer GK; Baum D; Gilleaudeau P; Sullivan-Whalen M; Fuentes-Duculan J; Li X; Zheng X; Estrada Y; Garcet S; Wen HC; Gonzalez J; Coats I; Cueto I; Neumann AU; Lebwohl MG; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2019 Jan; 143(1):142-154. PubMed ID: 30121291
[TBL] [Abstract][Full Text] [Related]
2. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.
Guttman-Yassky E; Bissonnette R; Ungar B; Suárez-Fariñas M; Ardeleanu M; Esaki H; Suprun M; Estrada Y; Xu H; Peng X; Silverberg JI; Menter A; Krueger JG; Zhang R; Chaudhry U; Swanson B; Graham NMH; Pirozzi G; Yancopoulos GD; D Hamilton JD
J Allergy Clin Immunol; 2019 Jan; 143(1):155-172. PubMed ID: 30194992
[TBL] [Abstract][Full Text] [Related]
3. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.
Hamilton JD; Suárez-Fariñas M; Dhingra N; Cardinale I; Li X; Kostic A; Ming JE; Radin AR; Krueger JG; Graham N; Yancopoulos GD; Pirozzi G; Guttman-Yassky E
J Allergy Clin Immunol; 2014 Dec; 134(6):1293-1300. PubMed ID: 25482871
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.
Suárez-Fariñas M; Dhingra N; Gittler J; Shemer A; Cardinale I; de Guzman Strong C; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2013 Aug; 132(2):361-70. PubMed ID: 23777851
[TBL] [Abstract][Full Text] [Related]
5. Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities.
He H; Del Duca E; Diaz A; Kim HJ; Gay-Mimbrera J; Zhang N; Wu J; Beaziz J; Estrada Y; Krueger JG; Pavel AB; Ruano J; Guttman-Yassky E
J Allergy Clin Immunol; 2021 Apr; 147(4):1369-1380. PubMed ID: 33011244
[TBL] [Abstract][Full Text] [Related]
6. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population.
Czarnowicki T; Gonzalez J; Shemer A; Malajian D; Xu H; Zheng X; Khattri S; Gilleaudeau P; Sullivan-Whalen M; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Jul; 136(1):104-115.e7. PubMed ID: 25748064
[TBL] [Abstract][Full Text] [Related]
7. Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin.
Correa da Rosa J; Malajian D; Shemer A; Rozenblit M; Dhingra N; Czarnowicki T; Khattri S; Ungar B; Finney R; Xu H; Zheng X; Estrada YD; Peng X; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Mar; 135(3):712-20. PubMed ID: 25583101
[TBL] [Abstract][Full Text] [Related]
8. Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma.
Badi YE; Pavel AB; Pavlidis S; Riley JH; Bates S; Kermani NZ; Knowles R; Kolmert J; Wheelock CE; Worsley S; Uddin M; Alving K; Bakke PS; Behndig A; Caruso M; Chanez P; Fleming LJ; Fowler SJ; Frey U; Howarth P; Horváth I; Krug N; Maitland-van der Zee AH; Montuschi P; Roberts G; Sanak M; Shaw DE; Singer F; Sterk PJ; Djukanovic R; Dahlen SE; Guo YK; Chung KF; Guttman-Yassky E; Adcock IM;
J Allergy Clin Immunol; 2022 Jan; 149(1):89-101. PubMed ID: 33891981
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial.
Guttman-Yassky E; Brunner PM; Neumann AU; Khattri S; Pavel AB; Malik K; Singer GK; Baum D; Gilleaudeau P; Sullivan-Whalen M; Rose S; Jim On S; Li X; Fuentes-Duculan J; Estrada Y; Garcet S; Traidl-Hoffmann C; Krueger JG; Lebwohl MG
J Am Acad Dermatol; 2018 May; 78(5):872-881.e6. PubMed ID: 29353025
[TBL] [Abstract][Full Text] [Related]
10. Atopic dermatitis in African American patients is T
Sanyal RD; Pavel AB; Glickman J; Chan TC; Zheng X; Zhang N; Cueto I; Peng X; Estrada Y; Fuentes-Duculan J; Alexis AF; Krueger JG; Guttman-Yassky E
Ann Allergy Asthma Immunol; 2019 Jan; 122(1):99-110.e6. PubMed ID: 30223113
[TBL] [Abstract][Full Text] [Related]
11. Early-onset pediatric atopic dermatitis is T
Esaki H; Brunner PM; Renert-Yuval Y; Czarnowicki T; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Johnson DB; Bauer B; Fuentes-Duculan J; Zheng X; Peng X; Estrada YD; Xu H; de Guzman Strong C; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
J Allergy Clin Immunol; 2016 Dec; 138(6):1639-1651. PubMed ID: 27671162
[TBL] [Abstract][Full Text] [Related]
12. Early-onset pediatric atopic dermatitis is characterized by T
Brunner PM; Israel A; Zhang N; Leonard A; Wen HC; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Wagner A; Zheng X; Estrada YD; Xu H; Krueger JG; Paller AS; Guttman-Yassky E
J Allergy Clin Immunol; 2018 Jun; 141(6):2094-2106. PubMed ID: 29731129
[TBL] [Abstract][Full Text] [Related]
13. Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing.
Suárez-Fariñas M; Ungar B; Noda S; Shroff A; Mansouri Y; Fuentes-Duculan J; Czernik A; Zheng X; Estrada YD; Xu H; Peng X; Shemer A; Krueger JG; Lebwohl MG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Nov; 136(5):1277-87. PubMed ID: 26316095
[TBL] [Abstract][Full Text] [Related]
14. The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults.
Renert-Yuval Y; Del Duca E; Pavel AB; Fang M; Lefferdink R; Wu J; Diaz A; Estrada YD; Canter T; Zhang N; Wagner A; Chamlin S; Krueger JG; Guttman-Yassky E; Paller AS
J Allergy Clin Immunol; 2021 Jul; 148(1):148-163. PubMed ID: 33453290
[TBL] [Abstract][Full Text] [Related]
15. GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis.
Guttman-Yassky E; Pavel AB; Zhou L; Estrada YD; Zhang N; Xu H; Peng X; Wen HC; Govas P; Gudi G; Ca V; Fang H; Salhi Y; Back J; Reddy V; Bissonnette R; Maari C; Grossman F; Wolff G
J Allergy Clin Immunol; 2019 Aug; 144(2):482-493.e7. PubMed ID: 30738171
[TBL] [Abstract][Full Text] [Related]
16. Increased IL-26 Expression Promotes T Helper Type 17- and T Helper Type 2-Associated Cytokine Production by Keratinocytes in Atopic Dermatitis.
Kamijo H; Miyagaki T; Hayashi Y; Akatsuka T; Watanabe-Otobe S; Oka T; Shishido-Takahashi N; Suga H; Sugaya M; Sato S
J Invest Dermatol; 2020 Mar; 140(3):636-644.e2. PubMed ID: 31465744
[TBL] [Abstract][Full Text] [Related]
17. CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22.
Hijnen D; Knol EF; Gent YY; Giovannone B; Beijn SJ; Kupper TS; Bruijnzeel-Koomen CA; Clark RA
J Invest Dermatol; 2013 Apr; 133(4):973-9. PubMed ID: 23223131
[TBL] [Abstract][Full Text] [Related]
18. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.
Noda S; Suárez-Fariñas M; Ungar B; Kim SJ; de Guzman Strong C; Xu H; Peng X; Estrada YD; Nakajima S; Honda T; Shin JU; Lee H; Krueger JG; Lee KH; Kabashima K; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Nov; 136(5):1254-64. PubMed ID: 26428954
[TBL] [Abstract][Full Text] [Related]
19. T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: at the origin of the problem.
Orciani M; Campanati A; Caffarini M; Ganzetti G; Consales V; Lucarini G; Offidani A; Di Primio R
Br J Dermatol; 2017 Jun; 176(6):1569-1576. PubMed ID: 27639070
[TBL] [Abstract][Full Text] [Related]
20. Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis.
Pavel AB; Song T; Kim HJ; Del Duca E; Krueger JG; Dubin C; Peng X; Xu H; Zhang N; Estrada YD; Denis L; Rao N; Gupta S; Zammit DJ; Bissonnette R; Guttman-Yassky E
J Allergy Clin Immunol; 2019 Oct; 144(4):1011-1024. PubMed ID: 31356921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
